MacroGenics (MGNX) Jeffrey S. Peters, GC & Secretary Sells 31,105 Shares

What Happened Jeffrey S. Peters, Senior Vice President, General Counsel and Secretary of MacroGenics, sold 31,105 shares of MGNX stock in an open-market transaction on August 19, 2026. The Form 4 reports an aggregate proceeds of $129,086 (reported price $4.15 per share), with the actual trades executed at prices ranging from $4.12 to $4.24. This was a sale (not a purchase), and sales by executives are often routine rather than a direct signal of company prospects.

Key Details

• Transaction date: 2026-08-19; Form 4 filed: 2026-08-20 (timely filing).
• Reported aggregate proceeds: $129,086; reported price shown as $4.15/share; executed prices ranged $4.12–$4.24 (multiple trades).
• Shares sold: 31,105 (transaction code S = Sale).
• Shares owned after transaction: not reported in the provided excerpt of the Form 4.
• Notable footnotes:
  • F1: Sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 20, 2026 (pre‑arranged plan).
  • F2: Multiple-trade execution; reporting person will provide, on request, the number of shares sold at each price within the reported range.

Context A 10b5-1 trading plan indicates these sales were pre-scheduled under a compliance plan and are typically viewed as routine. For retail investors, purchases can be a stronger signal than sales; this filing documents a planned disposition rather than an opportunistic or one-off trade.